Search Results

Baxter Reports First-Quarter 2021 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2021. 

Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research

Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF). With the grant, Baxter will lead an initiative aiming to create a new technology platform enhancing the ability to target selective removal of pathogenic substances during certain extracorporeal (outside the body) blood purification (EBP) therapies.

Baxter Recognized Globally for Inclusion Efforts

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countries for its inclusion efforts. Baxter Brazil, China, France, Germany, India, Ireland, Italy, Japan, Mexico, Singapore and the UK earned spots on the inaugural Index.

Baxter to Present at BofA Securities 2021 Virtual Health Care Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.  Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:45 a.m. Eastern Time.   The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through August 11, 2021.

Baxter to Host Its Annual Meeting of Stockholders in Virtual Format

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, its Annual Meeting of Stockholders (the 2021 Annual Meeting) will again be held by means of a virtual format only.

Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease

Baxter International Inc. (NYSE:BAX), a leading global medical products company, and the Central Area of The Links, Incorporated, an international not-for-profit comprised of 16,000 women of color, announce a new partnership to bring awareness and resources to the disproportionate challenges affecting Black Americans related to kidney health. Through the partnership, Baxter is committing $600,000 to fund grants to local Links chapters in the organization’s 17-state U.S.

Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thursday, April 29, 2021 at 7:30 a.m. Central Time.  To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/1693119 to pre-register for the call and receive the call information.

Baxter Announces U.S. FDA 510(K) Clearance of AK 98 Hemodialysis Machine

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation Artificial Kidney 98 (AK 98) dialysis machine, which is designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments.

Baxter to Present at Oppenheimer 31st Annual Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021.  Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through September 13, 2021.  

Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma Solutions (BPS) to provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.